Floatz logo

Immunoglobulin G1, Anti-(Human Cd Antigen Cd27) (Human Monoclonal Cdx-1127 Clone 1F5 Heavy Chain), Disulfide With Human Monoclonal Cdx-1127 Clone 1F5 .Kappa.-Chain, Dimer

B-Cell Non-Hodgkin Lymphoma

National Cancer Institute (NCI)monoclonal_antibodyPhase 2Active
CCC
51/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
36/ 100
Competitive Position
81/ 100

Competitive context

305 Active assets in the B-Cell Non-Hodgkin Lymphoma cohort.

Asset / SponsorPhaseRating
Vindesine
Children's Cancer Group, China
Phase 4BBB
Anti-Cd20/Cd3 Monoclonal Antibody Regn1979
University of Birmingham
Phase 3BBB
Cytarabine
Children's Cancer Group, China
Phase 4BBB
Methotrexate
Children's Cancer Group, China
Phase 4BBB
Camustine
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Phase 4BBB

View all 50 →

Same molecule, other indications

Immunoglobulin G1, Anti-(Human Cd Antigen Cd27) (Human Monoclonal Cdx-1127 Clone 1F5 Heavy Chain), Disulfide With Human Monoclonal Cdx-1127 Clone 1F5 .Kappa.-Chain, Dimer is also rated in:

melanomaDormant
CCC
Indicative · Phase 2
49 / 100
View asset →
Burkitt lymphomaActive
CCC
Indicative · Phase 2
48 / 100
View asset →
glioblastomaActive
CC
Indicative · Phase 2
47 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →